News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Conatus Pharmaceuticals Inc. Buys Back Idun Pharmaceuticals, Inc. From Pfizer Inc. (PFE)


8/2/2010 7:48:19 AM

PE Hub -- Conatus Pharmaceuticals, a San Diego-based drug company focused on inflammation and liver disease, has acquired the Idun Pharmaceuticals subsidiary of Pfizer Inc. No financial terms were disclosed. Conatus was founded in July 2005 by the executive management team of Idun Pharma, following its sale to Pfizer. It has raised around $27.5 million in VC funding, from Aberdare Ventures, Advent Venture Partners, Bay City Capital and Gilde Healthcare Partners.

Read at Private Equity Hub
Read at News Release
Read at BusinessWeek
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES